Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Recce Pharmaceuticals Ltd. (ASX: RCE) has requested a trading halt on its securities as it prepares to make a significant announcement regarding its Phase 3 Diabetic Foot Ulcer Infection Approval. The halt will remain until December 9, 2024, or until the announcement is released, creating anticipation among investors about the company’s future prospects.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.